EMA event supporting materials

EMA has selected this series of key materials for attendees of DIA so that you have quick access to information about how EMA works and its recent initiatives.

Check our interactive timeline to learn about each stage a medicine goes through from initial research to patient access, and about how EMA supports medicine development, assesses the benefits and risks of medicines and monitors their safety.

To find out more, see:

• Medicine evaluation figures

Learn about EMA's contribution to tackling the COVID-19 pandemic, by facilitating rapid access to .

Learn about the Clinical Trials Regulation, including how it overhauled the oversight of clinical trials in the EU, and EMA's new responsibilities in this area.

• Accelerating Clinical Trials in the EU (ACT EU)

Read our news announcement on the entry into application of the Veterinary Medicinal Products Regulation to find out how the Regulation changed the rules on the authorisation and use of veterinary medicines in the EU, and to learn about EMA's strengthened role in the veterinary field.

To find out more, see:

• Veterinary Medicinal Products Regulation

To find out more, see

• Supporting SMEs

To find out more, see:

• Advanced therapy medicinal products: Overview

To find out more, see:

• International activities

• Ongoing clinical trials raw data pilot
• Reflection paper on establishing efficacy based on single-arm trials submitted as pivotal evidence in a marketing authorisation
• Vaccine Monitoring Platform
• Guideline on registry-based studies
• Multi-stakeholder workshop on Real World Data (RWD) quality and Real World Evidence (RWE) use